Be The Match BioTherapies
Matt Mayr has extensive experience in sales and business development within the biotechnology and healthcare sectors. Currently serving as the Sales and Business Development Manager at NMDP BioTherapies since December 2018, Matt focuses on partnering with organizations involved in cellular therapies. Prior roles include Inside Sales Manager at Cell Culture Company, where responsibilities included enhancing the quality of bioreactor systems, and various positions at YP, contributing to the growth of local businesses through digital advertising solutions. Additional experience includes roles at MAPS Medical Pain Clinics, the Minnesota Timberwolves, and Learfield Sports. Matt holds a Bachelor of Science in Sports Management from the University of Minnesota.
Be The Match BioTherapies
Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies. We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja